July 9, 2026 · Form 4 insider transaction
Cook Jennifer E. bought 19,000 shares of BridgeBio Pharma, Inc. at $8.45 per share, a transaction worth $160.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 16, 2026.